Multi-Center Study on Migraine and Seizure-Related Headache in Patients with Epilepsy by 
Yonsei Med J   http://www.eymj.org    Volume 51   Number 2   March 2010 219
Migraine and epilepsy are both chronic neurological disorders characterized by
recurrent attacks, which are often found as comorbid conditions. The comorbidity
of migraine and epilepsy has been reported with the frequency of migraine in the
epileptic population ranging from 8% to 15%.
1 Headaches are often recognized as
a part of symptoms of epileptic seizures. The characteristics of seizure-related
headache (SRH) have been reported in many studies.
2-12 However, only a few studies
have been conducted on large patient populations (n > 300),
3,8,11 and the influence
of migraine on SRH has not been thoroughly investigated.
2,5,8,11 We prospectively
conducted a nationwide survey of migraine and SRH by using a questionnaire. 
Five hundred and ninety-seven epileptic patients from 32 outpatient clinics (36
epileptologists) were investigated at their initial visit by using a questionnaire.
Patients were ≥ 13 years of age and had experienced ≥ 2 seizures during the year
prior to their first visit. Patients with seizures only during sleep, overt mental
retardation, or impaired communication skills were excluded because these
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Purpose: The purpose of this study is to investigate the frequency and characteristics of migraine and seizure-
related headache (SRH) according to the criteria of the International Headache Society. Materials and Methods: A
questionnaire was undertaken at the initial evaluation of newly referred patients from 32 epilepsy clinics. Results:
Of a total of 597 patients, 74 (12.4%) patients had migraine. Age at the onset of epilepsy was lower in patients with
migraine than in those without. Twenty-six (4.4%), nine (1.5%), and 146 (24.5%) patients experienced prodromal,
ictal, and postictal SRH, respectively (n = 169, 28.3%). A pain intensity of prodromal and postictal SRH was 6.1 ±
1.5 (SD) and 6.3 ± 1.9 (SD) on the visual analogue scale, and their duration was 12.6 ± 26.7 (SD) hours and 9.0  ±
17.4 (SD) hours, respectively. Age at the onset of epilepsy was lower in patients with SRH than in those without,
and the risk of occurrence of SRH was significantly greater in patients with longer epilepsy duration. SRH could be
classified as a type of migraine in 46.2% of patients with prodromal SRH and in 36.3% of patients with postictal
SRH. Prodromal SRH occurred more frequently and was more likely to be a migraine-type in patients with
migraine compared with those without. Postictal SRH occurred more frequently and was more likely to be a
migraine-type in patients with migraine. Conclusion: This study suggests that SRH is a frequent accompanying
symptom of epileptic seizures causing major impairment in daily life, and migraine is an important comorbidity of
epilepsy, affecting the incidence and characteristics of SRH.
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INTRODUCTION
MATERIALS AND METHODS patients were unlikely to give reliable information regarding
their headaches. A diagnosis of migraine was made in
patients having interictal headaches that satisfy the criteria
of the International Headache Society (IHS).
13
The patients were given a questionnaire on SRH which
addressed frequency, quality, lateralization, duration,
severity, and accompanying symptoms. According to the
timing of the headaches in relation to the seizure, SRH was
classified as prodromal, ictal, and postictal headaches;
prodromal SRH was regarded as a headache that had
lasted for more than 10 minutes before the onset of overt
seizure, ictal SRH was a headache that had occurred alone
just before the onset of overt seizure or simultaneously
with the other seizure manifestations, and postictal SRH
was a headache that had begun immediately after cessation
of the seizure. Prodromal SRH and postictal SRH were
further classified into migraine-type by the IHS criteria,
regardless of the number or duration of attacks, and non-
migraine headaches were classified as other-type. 
The pain intensity of SRH was determined by the patients
on a visual analogue scale (VAS: 0, no pain; 10, strongest
pain). The frequency of SRH associated with seizures was
classified as: always (≥ 90% of seizures); frequent (50% to
89% of seizures); occasional (10% to 49% of seizures); and
rare (< 10% of seizures). The classification of seizure and
epilepsy, and the lobar classification of epileptogenic foci
were based on ictal semiology, EEG, and neuroimaging
findings.
14,15
We used the Student’s t-test to analyze continuous vari-
ables and the χ 2 test or Fisher’s exact test to examine cate-
gorical variables. The significance level was set at p < 0.05.
The study was approved by the Institutional Review Board
of Severance Hospital.
A total of 597 patients were enrolled (Table 1). Of these,
348 (58.3%) were men and 249 (41.7%) were women.
Patients’ ages ranged from 13 to 86 years, with a mean age
(± SD) of 34.9 (± 15.1) years. The mean age (± SD) at the
onset of epilepsy was 26.9 (± 16.1) years and the mean
duration (± SD) of epilepsy was 8.0 (± 10.2) years. Symp-
tomatic etiology was found in 243 (40.7%) patients. Three
hundred and forty (57.0%) patients had not taken antie-
pileptic drugs (AEDs) at the time of their initial visit to the
clinic. One hundred and sixteen (19.4%) patients had
generalized epilepsy; 69.0% (n = 80), 25.0% (n = 29), and
6.0% (n = 7) of the patients were classified as having
generalized tonic-clonic seizure (GTCS) only, juvenile
myoclonic epilepsy, and absence epilepsy, respectively. Of
those with partial epilepsy (n = 481, 80.6%), 3.1% (n = 15)
had simple partial seizure (SPS) only, 17.5% (n = 84) had
complex partial seizure (CPS) only, or SPS and CPS, and
79.4% (n = 382) had seizure types including secondarily
GTCS. The percentage of patients diagnosed as frontal
(FLE), temporal (TLE), parietal (PLE), and occipital (OLE)
lobe epilepsies were 26.0% (n = 125), 32.6% (n = 157),
5.4% (n = 26), and 2.1% (n = 10), respectively, according
to lobar classification. Lobar localization of the epilepto-
genic focus could not be determined in 33.9% (n = 163) of
the patients (unspecified partial epilepsy: UPE). The distri-
bution of secondarily GTCS differed significantly among
lobar epilepsies (88.0% of FLE, 64.3% of TLE, 73.1% of
PLE, 90.0% of OLE, and 87.7% of UPE; p< 0.001).
Migraine (interictal)
Seventy-four (12.4%) patients had migraine (without aura,
60; with aura, 14). Most of these patients (n = 73) had
experienced at least one attack of migraine within 1 year
before their initial visit. The mean age (± SD) at the onset
of migraine was 21.4 (± 8.8) years, and the mean duration
(± SD) of migraine was 9.4 (± 8.8) years. Migraine was
more frequent in women, younger patients, and patients
with younger age at the onset of epilepsy. The prevalence
was similar between those with generalized and partial
HELP (Headache in Epileptic Patients) Study Group
Yonsei Med J   http://www.eymj.org    Volume 51   Number 2   March 2010 220
RESULTS
Table 1.Demographic Data and Migraine (Interictal)
All patients  With migraine  Without migraine 
pvalue
(n = 597) (n = 74) (n = 523)
Sex (female) (%) 249 (41.7) 51 (68.9) 198 (37.9) < 0.001
Age at the initial visit, yrs 34.9 (15.1) (range 13 - 86) 31.0 (10.4) 35.4 (15.6) 0.002
Onset age of epilepsy, yrs 26.9 (16.1) (range 1 - 86) 21.6 (9.3) 27.7 (16.7) < 0.001
Epilepsy duration, years 8.0 (10.2) (range 0 - 50) 9.5 (10.5) 7.8 (10.1) 0.180
Untreated patients at the
340 (57.0) 36 (48.6) 304 (58.1) 0.123
initial visit (%)
Partial epilepsy (%) 481 (80.6) 58 (78.4) 423 (80.9)
0.611
Generalized epilepsy (%) 116 (19.4) 16 (21.6) 100 (19.1)
Symptomatic etiology (%) 243 (40.7) 25 (33.8) 218 (41.7) 0.195
Values are given as mean (SD). epilepsy (13.8% vs. 12.1%). The prevalence of migraine
was similar between the patients with and without sympto-
matic etiology (10.3% vs. 13.8%) (Table 1). Migraine was
found in 16.0% of FLE, 11.5% of TLE, 19.2% of PLE,
30.0% of OLE, and 7.4% of patients with UPE, which was
statistically significant (p= 0.033). 
Seizure-related headache
A total of 169 (28.3%) patients experienced SRH; 26 (4.4%),
9 (1.5%), and 146 (24.4%) patients had prodromal, ictal,
and postictal SRH, respectively. Ten patients had both
prodromal and postictal SRH and two patients had both
ictal and postictal SRH. The description of the headache
was consistent with migraine-type in 46.2% (n = 12) of
patients with prodromal SRH and in 36.3% (n = 53) of
patients with postictal SRH. Accompanying symptoms of
SRH, such as aggravation by routine physical activity,
nausea, vomiting, photophobia, and phonophobia, and a
history of drug ingestion for relief of SRH were found in a
significant number of patients and equally distributed
among those with prodromal and postictal SRH (Table 2).
The pain intensity of prodromal, ictal, and postictal SRH
was 6.1 (SD, 1.5; range, 4-10), 5.4 (SD, 2.5; range, 2.5-
9.5), and 6.3 (SD, 1.9; range, 2-10) on the VAS, and their
duration was 12.6 hours (SD, 26.7; range, 0.2-96), 157.2
seconds (SD, 152.2; range, 5-480), and 9.0 hours (SD,
17.4; range, 0.03-96), respectively. Postictal SRH always
occurred in 66.4% of the patients, which was a significantly
higher rate compared with 30.8% of patients with prodro-
mal SRH and 33.3% of patients with ictal SRH (Table 3). 
Age at the onset of epilepsy and age at the initial visit
were lower in patients with SRH than in those without, and
the risk of occurrence of SRH was significantly greater in
patients with longer epilepsy duration. Patients without
SRH had not been treated with AEDs more frequently
compared to those with SRH at their initial visit. According
to the seizure type, there was no significant difference in
the frequency of overall SRH or postictal SRH between
patients with GTCS (GTCS in generalized epilepsy, or
seizure types including secondarily GTCS in partial
epilepsy) and patients without GTCS (29.3% vs. 24.3%, p =
0.294; 25.9% vs. 18.3%, p = 0.085) (Table 4). In partial
Migraine and Seizure-Related Headache
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Table 3.Frequency of Seizure-Related Headache Associated with Seizures
Frequency
Seizure-related headache
Prodromal (n = 26) Ictal (n = 9) Postictal (n = 146)
Always occurred* (%) (90 - 100%) 8 (30.8) 3 (33.3) 97 (66.4)
Frequently occurred (%) (50 - 89%) 15 (57.7) 4 (44.4) 28 (19.2)
Occasionally occurred (%) (10 - 49%) 1 (3.8) 0 (0.0) 16 (11.0)
Rarely occurred (%) (0 - 9%) 2 (7.7) 2 (22.2) 5 (3.4)
*p= 0.001 (always vs. not always).
Table 2.Accompanying Symptoms and a History of Drug Ingestion in Seizure-Related Headache
Prodromal (n = 26) Postictal (n = 146)
Aggravation by routine physical activity (%) 10 (38.5) 47 (32.2)
Nausea or vomiting (%) 10 (38.5) 53 (36.3)
Photophobia (%) 9 (34.6) 40 (27.4)
Phonophobia (%) 10 (38.5) 57 (39.0)
History of drug ingestion (%) 20 (76.9) 95 (65.1)
Table 4.Seizure-Related Headache and Demographic Data 
With seizure-related Without seizure-related
pvalue
headache (n = 169) headache (n = 428)
Sex (male) (%) 93 (55.0) 255 (59.6) 0.31
Age at the initial visit, yrs 32.0 (13.9) 36.1 (15.4) 0.002
Onset age of epilepsy, yrs            22.1 (13.1) 28.8 (16.7) < 0.001
Epilepsy duration, yrs                9.9 (10.9) 7.3 (9.8) 0.009
Untreated patients at the initial visit (%)           83 (49.1) 257 (60.0) 0.015
With GTCS (%) 141 (83.4) 341 (79.7) 0.294
GTCS, generalized tonic-clonic seizure. 
Values are given as mean (SD). epilepsy, SRH was found in 13.3% of patients with SPS
only, 26.2% of patients with CPS only or with SPS and
CPS, and 28.3% of patients with seizure types including
secondarily GTCS, which was not statistically significant
(p = 0.488). Also, there was no significant difference in the
frequency of postictal SRH (6.7%, 19.0%, and 24.9%; p =
0.172). According to the lobar classification, SRH occurred
in 37.6% of FLE, 23.6% of TLE, 30.8% of PLE, 50.0% of
OLE, and 21.5% of patients with UPE, which was statisti-
cally significant (p = 0.010). There was no significant dif-
ference in the frequency of postictal SRH among lobar
epilepsies (31.2% of FLE, 20.4% of TLE, 19.2% of PLE,
40.0% of OLE, and 20.9% of UPE; p = 0.085). A signifi-
cant relationship was not found between seizure type and
the intensity or frequency (in association with seizure) of
the SRH (data not shown). 
The influence of migraine on the type of seizure-related
headache
Postictal SRH occurred more frequently (35.1% vs. 22.9%,
p = 0.022) and was more likely to be a migraine-type
(61.5% vs. 30.8%, p = 0.003) in patients with migraine
compared to those without. Also, prodromal SRH occurred
more frequently (10.8% vs. 3.4%; p = 0.009) and was
more likely to be a migraine-type (75.0% vs. 33.3%, p =
0.090) in patients with migraine (Table 5). 
Abundant clinical and epidemiologic data demonstrates
that migraine and epilepsy are highly comorbid. Ander-
mann and Andermann
1 summarized a number of studies
that investigated the association between migraine and
epilepsy. The prevalence of epilepsy in persons with mig-
raine ranged from 1% to 17% with a median of 5.9%, sub-
stantially higher than the population prevalence of epilepsy
of 0.5%. Migraine prevalence in patients with epilepsy
ranged from 8% to 15%. In an epidemiological study, the
cumulative incidence of migraine by age 40 was 24% in
probands with epilepsy, 23% in relatives with epilepsy, and
12% in relatives without epilepsy, which indicate that mig-
raine and epilepsy are strongly associated.
16 Several studies
that were performed on a small number of epilepsy patients
(n = 100 to 412) reported various results in the prevalence
of migraine ranging from 8% to 20%.
2,4,8,9,11,17-19 In this study,
migraine was found in 12.4% of 597 patients, which is
higher than the prevalence of 6.5% in the general Korean
population (n = 1,523).
20 The frequency of migraine with
aura in the patients with migraine in this study was similar
to that of the general Korean population with migraine
(18.9% vs. 20.2%),
20 which is in contrast with the study by
Leniger, et al.
19 showing that migraine with aura was signi-
ficantly more frequent in patients with epilepsy and mig-
raine compared with those with migraine alone. Ottman
and Lipton
16 reported that age at the onset of epilepsy was
not a significant predictor of migraine, and Veliog ̌lu, et al.
21
reported that patients with epilepsy and migraine had a
longer duration of epilepsy compared to those with epilepsy
alone. In this study, the presence of migraine was associated
with a younger age at the onset of epilepsy and at the initial
visit, but not with a longer duration of epilepsy. Although
our results suggest that epilepsy of earlier onset could inc-
rease the risk of migraine, further studies are required. 
In this study, overall SRH occurred in 28% of all patients,
which is lower than the frequency of 34% to 59% reported
in previous studies.
8,9,12 Also, the frequency of postictal
SRH (24%) seems to be lower than the 23% to 52% re-
ported in previous studies.
2-12 This finding might be due to
the inclusion of more patients with milder disease activity
compared with other studies. In this study, 57% of all
patients were untreated, and presumed to have drug-naive
epilepsy. These patients were less likely to have SRH
compared with those being treated for their epilepsy. 
SRH, as well as seizures, significantly disturbs daily life.
The pain intensity of SRH was 5.4 to 6.3 on average on the
VAS, indicating a moderate to severe intensity. Moreover,
prodromal and postictal SRH lasted 12.6 and 9.0 hours on
average, respectively, and were accompanied by several
annoying symptoms. The majority of patients with SRH
HELP (Headache in Epileptic Patients) Study Group
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DISCUSSION
Table 5.Migraine (interictal) and Seizure-Related Headache
Seizure-related headache  With migraine (n = 74) Without migraine (n = 523)
Prodromal* (%) 8 (10.8) 18 (3.4)
Migraine-type
� (%) 6 (75.0) 6 (33.3)
Other-type (%)  2 (25.0) 12 (66.7)
Ictal (%) 1 (1.4) 8 (1.5)
Postictal
� (%) 26 (35.1) 120 (22.9)
Migraine-type
§ (%) 16 (61.5) 37 (30.8)
Other-type (%) 10 (38.5) 83 (69.2)
*p= 0.009; 
�p= 0.090; 
�p= 0.022; 
§p= 0.003.had taken drugs for headache control. Among the patients
with postictal SRH, 66% always experienced headaches in
combination with their seizures, which was much more
frequent compared to prodromal or ictal SRH. This agrees
with the results reported by Leniger, et al.
8 who observed a
consistent appearance of SRH in 60% of the epilepsy
patients with SRH. 
The classification of SRH has been performed in previous
studies. Fördereuther, et al.
7 classified 34% of the patients
with postictal SRH as having migraine headaches, and Ito,
et al.
11 observed migraine-like headaches in 26% of the
patients with postictal SRH. Leniger, et al.
8 reported that
56% of the patients with SRH experienced migraine-like
headaches. Yankovsky, et al.
12 reported that 36% of the
patients with preictal headaches (prodromal and ictal SRH)
and 48% of those with postictal headaches had migraine-
like headaches. In this study, migraine-type (migraine-like)
headaches were found in 46% and 36% of the patients
with prodromal and postictal SRH, respectively. Also, it is
interesting that the prevalence of migraine was significantly
higher in patients with SRH and migraine-type SRH, which
was in agreement with previous studies. Ito and Schachter
5
found that postictal SRH occurred more frequently in pa-
tients with interictal headaches (presumed to be migraine
in many cases), and Leniger, et al.
8 and Ito, et al.
11 reported
a significant association between migraine-like SRH and
migraine. Therefore, it is likely that there is a link between
migraine, SRH, and migraine-like SRH. Although the
mechanism of SRH is uncertain, the trigeminovascular
system, which has been theorized to play a role in the patho-
genesis of a migraine, may be activated by seizures.
22
The presence of migraine and SRH seems to be related
to the region of epileptogenic focus. In this study, determi-
nation of lobar epilepsy was often difficult to make on the
outpatient basis, and might be affected by each investi-
gator’s bias. Also, the small number of patients with OLE
(n = 10) may prohibit drawing any meaningful conclusion
about the relationship between migraine or SRH, and OLE.
However, the frequency of migraine and SRH seems to be
higher in patients with OLE; 30% and 50% of patients
with OLE had migraine and SRH, respectively, and four of
the five patients with SRH had migraine-type headaches
(data not shown in Results). A higher frequency of postictal
headache and migraine-like postictal headache in OLE has
been reported already.
4,6,11 Cortical spreading depression is
considered to be the mechanism of migraine aura, and cha-
racterized by transient increases in metabolic and electrical
activity, and cerebral blood flow, followed by sustained
decreases, spreading from the posterior to anterior cerebral
area.
23 Therefore, the occipital lobe could be the brain struc-
ture most responsible for the development of migraine.
Migraine, SRH, and migraine-like SRH might be more
likely to occur in association with OLE.
In conclusion, this study suggests that migraine is a
frequent comorbidity in epilepsy patients and an important
factor affecting the occurrence and character of SRH. This
study also demonstrates that SRH is a frequent accom-
panying symptom of epileptic seizure, causing major
impairment in daily life. The links between epilepsy,
migraine, and SRH are an important subject for future
investigation. 
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